Switch theme
Sign up to access all valuation multiples
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.
2008
179
LTM Revenue $11.5M
LTM EBITDA -$48.7M
$113M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Carmat has a last 12-month revenue (LTM) of $11.5M and a last 12-month EBITDA of -$48.7M.
In the most recent fiscal year, Carmat achieved revenue of $7.9M and an EBITDA of -$55.6M.
Carmat expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Carmat valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $11.5M | XXX | $7.9M | XXX | XXX | XXX |
| Gross Profit | $11.5M | XXX | -$26.5M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | -337% | XXX | XXX | XXX |
| EBITDA | -$48.7M | XXX | -$55.6M | XXX | XXX | XXX |
| EBITDA Margin | -423% | XXX | -707% | XXX | XXX | XXX |
| EBIT | -$50.7M | XXX | -$45.1M | XXX | XXX | XXX |
| EBIT Margin | -441% | XXX | -573% | XXX | XXX | XXX |
| Net Profit | -$52.0M | XXX | -$57.7M | XXX | XXX | XXX |
| Net Margin | -452% | XXX | -734% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $59.6M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Carmat's stock price is EUR 1 (or $1).
Carmat has current market cap of EUR 47.5M (or $53.4M), and EV of EUR 101M (or $113M).
See Carmat trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $113M | $53.4M | XXX | XXX | XXX | XXX | $-1.12 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Carmat has market cap of $53.4M and EV of $113M.
Carmat's trades at 14.4x EV/Revenue multiple, and -2.0x EV/EBITDA.
Equity research analysts estimate Carmat's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Carmat has a P/E ratio of -1.0x.
See valuation multiples for Carmat and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $53.4M | XXX | $53.4M | XXX | XXX | XXX |
| EV (current) | $113M | XXX | $113M | XXX | XXX | XXX |
| EV/Revenue | 9.8x | XXX | 14.4x | XXX | XXX | XXX |
| EV/EBITDA | -2.3x | XXX | -2.0x | XXX | XXX | XXX |
| EV/EBIT | -2.2x | XXX | -2.5x | XXX | XXX | XXX |
| EV/Gross Profit | 9.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | -1.0x | XXX | -0.9x | XXX | XXX | XXX |
| EV/FCF | -2.2x | XXX | -2.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialCarmat's last 12 month revenue growth is 150%
Carmat's revenue per employee in the last FY averaged $44K, while opex per employee averaged $0.1M for the same period.
Carmat's rule of 40 is -1474% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Carmat's rule of X is -49% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Carmat and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 150% | XXX | 141% | XXX | XXX | XXX |
| EBITDA Margin | -423% | XXX | -707% | XXX | XXX | XXX |
| EBITDA Growth | -25% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -1474% | XXX | -558% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -49% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $44K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 236% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Carmat acquired XXX companies to date.
Last acquisition by Carmat was XXXXXXXX, XXXXX XXXXX XXXXXX . Carmat acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Carmat founded? | Carmat was founded in 2008. |
| Where is Carmat headquartered? | Carmat is headquartered in France. |
| How many employees does Carmat have? | As of today, Carmat has 179 employees. |
| Who is the CEO of Carmat? | Carmat's CEO is Mr. Stephane Piat. |
| Is Carmat publicy listed? | Yes, Carmat is a public company listed on PAR. |
| What is the stock symbol of Carmat? | Carmat trades under ALCAR ticker. |
| When did Carmat go public? | Carmat went public in 2010. |
| Who are competitors of Carmat? | Similar companies to Carmat include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Carmat? | Carmat's current market cap is $53.4M |
| What is the current revenue of Carmat? | Carmat's last 12 months revenue is $11.5M. |
| What is the current revenue growth of Carmat? | Carmat revenue growth (NTM/LTM) is 150%. |
| What is the current EV/Revenue multiple of Carmat? | Current revenue multiple of Carmat is 9.8x. |
| Is Carmat profitable? | Yes, Carmat is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Carmat? | Carmat's last 12 months EBITDA is -$48.7M. |
| What is Carmat's EBITDA margin? | Carmat's last 12 months EBITDA margin is -423%. |
| What is the current EV/EBITDA multiple of Carmat? | Current EBITDA multiple of Carmat is -2.3x. |
| What is the current FCF of Carmat? | Carmat's last 12 months FCF is -$52.5M. |
| What is Carmat's FCF margin? | Carmat's last 12 months FCF margin is -456%. |
| What is the current EV/FCF multiple of Carmat? | Current FCF multiple of Carmat is -2.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
